EDITAS MEDICINE INC's ticker is EDIT and the CUSIP is 28106W103. A total of 253 filers reported holding EDITAS MEDICINE INC in Q1 2022. The put-call ratio across all filers is 1.27 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $124,019 | -30.7% | 17,106 | +16.9% | 0.01% | -35.7% |
| Q3 2022 | $179,000 | +306.8% | 14,636 | +522.0% | 0.01% | +250.0% |
| Q1 2022 | $44,000 | -86.7% | 2,353 | -70.3% | 0.00% | -87.5% |
| Q1 2021 | $332,000 | +2666.7% | 7,928 | +4304.4% | 0.03% | +3100.0% |
| Q4 2020 | $12,000 | +200.0% | 180 | +9.8% | 0.00% | 0.0% |
| Q2 2020 | $4,000 | -96.3% | 164 | -95.6% | 0.00% | -90.9% |
| Q4 2019 | $109,000 | +626.7% | 3,700 | +428.6% | 0.01% | +1000.0% |
| Q3 2019 | $15,000 | -94.3% | 700 | -90.5% | 0.00% | -94.4% |
| Q2 2018 | $262,000 | +303.1% | 7,335 | +270.6% | 0.02% | +200.0% |
| Q1 2018 | $65,000 | -44.9% | 1,979 | -60.0% | 0.01% | -45.5% |
| Q3 2017 | $118,000 | +84.4% | 4,947 | +27.8% | 0.01% | +83.3% |
| Q2 2017 | $64,000 | -30.4% | 3,870 | -6.7% | 0.01% | -40.0% |
| Q1 2017 | $92,000 | – | 4,146 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NIA IMPACT ADVISORS, LLC | 54,615 | $4,897,000 | 2.55% |
| Capital Impact Advisors, LLC | 130,000 | $9,114,000 | 2.24% |
| ARK Investment Management | 10,125,564 | $709,903,000 | 1.89% |
| Nikko Asset Management Americas, Inc. | 4,388,143 | $307,653,000 | 1.75% |
| Spectrum Planning & Advisory Services Inc. | 17,522 | $1,228,000 | 1.32% |
| DDD Partners, LLC | 79,527 | $5,576,000 | 1.10% |
| Brevan Howard Capital Management LP | 76,420 | $5,358,000 | 1.08% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 538,721 | $37,770,000 | 0.75% |
| DC Investments Management, LLC | 3,627 | $254,000 | 0.63% |
| Haafor (Singapore) Pte. Ltd. | 4,761 | $334,000 | 0.62% |